Status:
UNKNOWN
Human Beta-defensin 1 in Vitiligo
Lead Sponsor:
Cairo University
Conditions:
Vitiligo
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
There is a need to know the role of human beta defensin-1 in vitiligo pathogenesis and the probability of finding newer and effective therapy for vitiligo in the future.
Eligibility Criteria
Inclusion
- Patients with non-segmental vitiligo.
- Both genders.
- Age more than 18 years old.
- New cases or cases not receiving any treatment for at least 3 months prior to the study.
Exclusion
- Universal or segmental vitiligo.
- Any contraindication to phototherapy treatment.
- History of autoimmune diseases or other systemic diseases.
- Any other skin disease.
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT03832751
Start Date
March 1 2019
End Date
December 1 2019
Last Update
February 6 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.